Dominant negative mutants of Myc inhibit cooperation of both Myc and adenovirus serotype-5 E1a with Ras - PubMed (original) (raw)
Dominant negative mutants of Myc inhibit cooperation of both Myc and adenovirus serotype-5 E1a with Ras
D MacGregor et al. J Cell Physiol. 1996 Apr.
Abstract
We have used dominant negative Myc mutants to analyze the Myc and E1a mechanisms of cooperation with Ras. We show that mutants of Myc with an altered basic region (BR; RR366, 367EE) or deletion of the leucine zipper (LZ; delta aa 414-439), changes which modify the DNA binding domain, or with deletions in the Myc amino terminal conserved regions box 1 (dlMB1; delta aa 46-55) and box 2 (dlMB2; delta aa 132-140) inhibit cooperation of wt Myc and activated Ras to transform rat embryo fibroblasts (REF). Expression of the amino terminal 104 aa had no effect whereas wt Myc stimulated focus formation. Mutant dlMB1 cooperated with Ras with one half wt efficiency while dlMB2 was inactive. No mutant tested was toxic during neomycin cotransformation of REF to G418 resistance. Interestingly, these Myc mutants exerted a parallel inhibition of E1a-Ras cooperation to transform REF. This suggests that the Myc-Ras and E1a-Ras cooperation pathways intersect and require common protein factors. A Myc box 2 deletion mutant which is a wt transactivator of the Myc responsive ornithine decarboxylase promoter, but unlike the wt does not repress the adenovirus-2 core promoter (Li et al., 1994, EMBO J., 13:4070-4079), inhibits Myc-Ras and E1a-Ras cooperation. This suggests that a box 2-dependent step, potentially gene repression, is required for both the E1a- and Myc-Ras cooperation mechanisms.
Similar articles
- Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL, Tanida S, Rodrigue AA, Johnson JK, Tompkins VS, Sakamuro D. Kinney EL, et al. J Cell Physiol. 2008 Sep;216(3):621-31. doi: 10.1002/jcp.21437. J Cell Physiol. 2008. PMID: 18348166 - Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
Elliott K, Sakamuro D, Basu A, Du W, Wunner W, Staller P, Gaubatz S, Zhang H, Prochownik E, Eilers M, Prendergast GC. Elliott K, et al. Oncogene. 1999 Jun 17;18(24):3564-73. doi: 10.1038/sj.onc.1202670. Oncogene. 1999. PMID: 10380878 - Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C, Chen N, Sawadogo M. Choe C, et al. Exp Cell Res. 2005 Jan 1;302(1):1-10. doi: 10.1016/j.yexcr.2004.08.013. Exp Cell Res. 2005. PMID: 15541720 - Adenoviral E1A function through Myc.
Chakraborty AA, Tansey WP. Chakraborty AA, et al. Cancer Res. 2009 Jan 1;69(1):6-9. doi: 10.1158/0008-5472.CAN-08-3026. Cancer Res. 2009. PMID: 19117980 Review.
Cited by
- Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells.
Watnick RS, Rodriguez RK, Wang S, Blois AL, Rangarajan A, Ince T, Weinberg RA. Watnick RS, et al. Oncogene. 2015 May 28;34(22):2823-35. doi: 10.1038/onc.2014.228. Epub 2014 Aug 11. Oncogene. 2015. PMID: 25109329 Free PMC article. - The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc.
McMahon SB, Wood MA, Cole MD. McMahon SB, et al. Mol Cell Biol. 2000 Jan;20(2):556-62. doi: 10.1128/MCB.20.2.556-562.2000. Mol Cell Biol. 2000. PMID: 10611234 Free PMC article. - Wnt and FGF signals interact to coordinate growth with cell fate specification during limb development.
ten Berge D, Brugmann SA, Helms JA, Nusse R. ten Berge D, et al. Development. 2008 Oct;135(19):3247-57. doi: 10.1242/dev.023176. Development. 2008. PMID: 18776145 Free PMC article. - Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors.
Jayachandra S, Low KG, Thlick AE, Yu J, Ling PD, Chang Y, Moore PS. Jayachandra S, et al. Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11566-71. doi: 10.1073/pnas.96.20.11566. Proc Natl Acad Sci U S A. 1999. PMID: 10500217 Free PMC article. Retracted. - A general method to design dominant negatives to B-HLHZip proteins that abolish DNA binding.
Krylov D, Kasai K, Echlin DR, Taparowsky EJ, Arnheiter H, Vinson C. Krylov D, et al. Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12274-9. doi: 10.1073/pnas.94.23.12274. Proc Natl Acad Sci U S A. 1997. PMID: 9356439 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources